Teva Pharmaceutical Finance to redeem $1 billion senior notes due 2014

By Ashley Montgomery

Kansas City, Kan., Dec. 18 - Teva Pharmaceutical Industries Ltd. subsidiary Teva Pharmaceutical Finance IV, LLC called its $1 billion 1.7% senior notes due 2014, according to a notice.

The notes will be redeemed on Jan. 7 at par plus accrued interest from Nov. 10 up to the redemption date.

The company said it would fund the redemption with proceeds from its $2 billion offering of senior notes.

Bank of New York Mellon is the trustee.

Teva is a Petach Tikva, Israel-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.